Amlodipine/Benazepril

Amlodipine and benazepril are prescription medications commonly used together to treat high blood pressure (hypertension). Amlodipine is a long-acting calcium channel blocker that relaxes and widens blood vessels by limiting calcium entry into vascular smooth muscle, which helps lower blood pressure and improve blood flow.

Benazepril is an angiotensin-converting enzyme (ACE) inhibitor that reduces the production of angiotensin II, a hormone that causes blood vessels to constrict. By decreasing angiotensin II levels, benazepril further promotes blood vessel relaxation and lowers blood pressure.

Used together, these medications provide complementary blood-pressure control by targeting vascular resistance through distinct mechanisms.

Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.

What is Lotrel?

Lotrel is the brand-name combination of amlodipine and benazepril, prescribed for the management of hypertension. By pairing a calcium channel blocker with an ACE inhibitor, Lotrel delivers more consistent blood pressure reduction than either medication alone.

This combination is typically prescribed for patients whose blood pressure is not adequately controlled with single-drug therapy. Effective blood pressure management with medications like Lotrel helps reduce the risk of serious cardiovascular complications, including heart attack, stroke, and kidney damage.

Lotrel should be taken exactly as prescribed and monitored regularly by a healthcare provider to ensure safe and effective blood pressure control.

Lotrel is primarily prescribed to manage high blood pressure, a condition characterized by the elevated force exerted by blood against arterial walls. By effectively lowering blood pressure, it lessens the risk of complications associated with hypertension, including strokes, heart attacks, and potential kidney impairment.

Primary Indications

Lotrel is indicated for treating hypertension in patients who may benefit from simultaneous interventions via a calcium channel blocker and an ACE inhibitor. For individuals whose hypertension cannot be controlled with a single class of blood pressure medication, Lotrel provides a dual-action remedy.

The combined effects of its constituents, Amlodipine and Benazepril, target multiple pathways involved in hypertension, making it a potent option for treating hypertension.

Other Uses

Beyond its primary indication for hypertension, Lotrel may occasionally be prescribed for other cardiovascular-related concerns at the discretion of a healthcare provider. This can include scenarios where enhanced vasodilatory or blood pressure-lowering effects are deemed beneficial for patient health.

Lotrel exerts its effects through the synergistic actions of its constituent drugs, amlodipine and benazepril. These medications collectively facilitate vasodilation, lower vascular resistance, and ultimately reduce blood pressure.

Mechanism of Action

• Amlodipine: functions by blocking calcium influx into cardiac and smooth muscle cells. This blockade relaxes and widens blood vessels, allowing blood to flow more freely and with less resistance, thus lowering blood pressure.
• Benazepril: acts by inhibiting the angiotensin-converting enzyme, preventing the formation of angiotensin II, a potent vasoconstrictor. With reduced angiotensin II levels, blood vessels remain relaxed, thereby enhancing the effect of amlodipine.

Pharmacokinetics

Understanding how Lotrel’s components are absorbed, metabolized, and excreted can help appreciate their pharmacologic effects. Both amlodipine and benazepril are well absorbed orally, with peak plasma concentrations achieved within hours of administration.

Amlodipine undergoes extensive hepatic metabolism, while benazepril is hydrolyzed to its active form, benazeprilat, primarily in the liver. Amlodipine is eliminated primarily via urine, similarly to benazepril and benazeprilat.

Lotrel is typically prescribed on a patient-specific basis, with dosages adjusted to optimize therapeutic efficacy and minimize side effects.

Dosage Guidelines

• Initial Dose: The initiation of Lotrel therapy often begins with a lower dose to assess patient response and tolerance.
• Titration: Depending on the therapeutic response and any side effects, the dosage may be adjusted incrementally to achieve desired blood pressure control.

Patients may receive different dosage combinations of amlodipine and benazepril, based on their healthcare provider’s clinical judgment and individual needs.

Administration Guidelines

• Route: Lotrel is administered orally, usually as a once-daily capsule.
• Frequency: Consistent dosing at the same time each day, with or without food, helps maintain stable plasma drug levels and enhances treatment effectiveness.

Patients are advised to follow their prescribed regimen closely, as deviations can affect blood pressure control and overall health outcomes.

While Lotrel is generally well-tolerated, some individuals may experience side effects. It is crucial to be aware of these potential adverse reactions to manage them effectively and notify a physician when necessary.

Common Side Effects

• Dizziness: Lightheadedness may occur—particularly when standing up quickly—as blood pressure lowers. Rising slowly from seated or lying positions can reduce symptoms.
• Swelling (Peripheral Edema): Amlodipine can cause swelling of the feet, ankles, or lower legs. While usually mild, persistent edema should be evaluated, as dose adjustments or additional therapy may be needed.
• Headache: Headaches may appear as the body adjusts to treatment. These are typically temporary, but should be discussed if severe or persistent.

Serious Side Effects

• Severe Allergic Reactions: Symptoms such as facial or throat swelling, difficulty breathing, rash, or severe dizziness require immediate medical care. These may indicate angioedema, a rare but serious reaction more commonly associated with ACE inhibitors.
• Increased Potassium Levels: Because benazepril can raise potassium levels, some individuals may develop hyperkalemia, which may cause weakness, abnormal heart rhythms, or numbness. Routine blood tests help monitor potassium levels.
  • “Salt Substitute” Warning: Many people trying to lower their blood pressure switch to low-sodium salts (like No-Salt). These products replace sodium with potassium chloride. However, combining Lotrel with potassium-based salt substitutes can lead to dangerously high blood potassium (hyperkalemia). This can cause “silent” heart rhythm disturbances that are potentially fatal. Use herbs and spices for flavor instead of potassium-based salt substitutes while taking Lotrel.
• Chest Pain or Heart Attack: Rarely, Lotrel may worsen chest pain initially or contribute to more serious cardiac events such as a heart attack. Any new or worsening chest discomfort should be evaluated promptly.

Kidney Function Changes: ACE inhibitors like benazepril can impact kidney function. Patients with existing kidney issues or taking other kidney-affecting medications may require close monitoring.

Because Lotrel combines two medications—a calcium channel blocker (amlodipine) and an ACE inhibitor (benazepril)—it can interact with a variety of drugs, supplements, and even certain foods.

These interactions may affect blood pressure control or increase the likelihood of adverse effects. Understanding them is essential for safe and effective treatment.

Drug Interactions

• Potassium Supplements: Lotrel can raise potassium levels due to its ACE inhibitor component. Taking additional potassium supplements, salt substitutes containing potassium, or potassium-sparing diuretics (such as spironolactone or triamterene) may further raise potassium levels, increasing the risk of hyperkalemia, which can cause muscle weakness or abnormal heart rhythms. Regular monitoring is recommended.
• Other Antihypertensives: Using Lotrel alongside other blood pressure medications—such as beta-blockers, ARBs, diuretics, or nitrates—can enhance blood-pressure-lowering effects. While this combination can benefit some patients, it may also cause excessive hypotension, leading to dizziness or fainting. Dose adjustments and careful monitoring may be required.
• NSAIDs: Frequent or long-term use of NSAIDs may reduce the blood-pressure-lowering effects of Lotrel and can impair kidney function, especially in older adults or those with pre-existing kidney disease. Healthcare providers may recommend limiting NSAID use or monitoring kidney function more closely.
• Lithium: Concomitant use with ACE inhibitors like benazepril may raise lithium levels and increase the risk of toxicity. If used together, lithium levels should be monitored.

Food and Alcohol

Alcohol consumption should be moderated, as it may amplify the blood-pressure-lowering effects and enhance dizziness or drowsiness. Additionally, patients should be cautious of consuming potassium-rich foods to avoid hyperkalemia.